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Abstract
Chronic kidney disease is a progressive and irreversible 
loss of the kidney function. Besides physical and treatment 
complications for chronic kidney disease, kidney patients 
also suffer a number of psychological problems, among 
which depression and anxiety are very common. This all, 
not only makes chronic kidney patients’, already difficult 
life, more difficult but also furthermore vulnerable and 
at risk for earlier death. This study aimed to measure 
the level of anxiety and depression of chronic kidney 
disease patients have been measured and compared with 
the scores of healthy participants. Since haemodialysis 
is the most common treatment method for CKD, 60 
haemodialysis patients at Inegol hospital in Turkey and 
60 people from a general healthy population (N=120) 
were conveniently chosen to participate in this study. 
Following the literature review indicating possible 
psychological outcomes of chronic kidney failure and 
haemodialysis, depression and anxiety level among 
CKD patients and healthy cohort group was measured. 
Depression and anxiety levels were investigated using 
the Beck Depression Inventory II and The State-Trait 
Anxiety Inventory were used (Turkish versions). Study 
results indicate, when compared to healthy cohorts 
(M=12.66, s.d. 5.7), CKD patients scored higher on 
depression scale (M=18.5, s.d. 7.3) as well as higher 
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level of anxiety (M=40.76, s.d.10.7) when compared 
with a healthy population (M=32.40, s.d. 7.8). Results 
of this study, next to important scientific contribution, 
indicate importance and the need for professional help 
psychological support for chronic kidney disease patients 
in order to diminish the psychological impact of facing 
chronic illness.
Keywords: Chronic kidney disease, depression, anxiety, 
chronic kidney patients, a general population
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INTRODUCTION
Chronic kidney disease, also called, end-stage renal disease is becoming 
one of the major public health concerns all over the world. The prevalence 
of end-stage renal disease (ESRD) is expected to rise around 7% of the 
whole World population and this will cost about 1.1 trillion dollars in 
medical expenditures (Lysaght, 2002). According to the Turkish Public 
Health Institute (2014), the prevalence of chronic kidney disease in Turkey 
is 15.7% which means 7.5 million people have been diagnosed with 
chronic kidney disease. The same source indicates increasing number of 
hemodialysis patients stating the number increased 3.6 times from1995 to 
2014 (The Ministry of Health of Turkey, 2014). Since there is no cure for 
CKD, kidney transplant or dialysis are the most common treatment methods. 
Hemodialysis, although generally provided at hemodialysis centers at 
hospitals it is also possible to get home dialysis but research indicates 
more positive outcomes of hemodialysis in hospitals (National Institute of 
Diabetes and Digestive and Kidney Diseases, 2016). Besides facing chronic 
physical health condition, although rarely timely and properly diagnosed, 
chronic kidney patients face several psychological problems such as 
anxiety and depression. Despite poor chances to diagnose psychological 
problems of CKD patients, depression is the most common psychological 
problem among CKD patients (Bossola et al., 2010) and it is found to be 
very much prevalent among CKD patients, affecting up to 20% of CKD 
patients even before the initiation of dialysis (Hedayati et al., 2009). At 
the same time, there is a bidirectional relationship between depression and 
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chronic medical illnesses due to the health risk behaviors and changes in 
the brain caused by depression which, in turn, increases the risk for chronic 
medical illnesses (Katon, 2011). Besides physical changes in chronic 
kidney patients (Goldberg, 2010) which might underlie the development 
of depression, other possible reasons for depression development among 
chronic illness patients are related to experiencing multiple pain (Dworkin 
et al.,1990), and stress due the change of lifestyle (Prince et al., 2007). 
Additionally, expected and commonly occurring decrease in the overall 
quality of life of chronic kidney patients makes patients more prone to 
develop psychological problems such as depression and anxiety (Ottaviani 
et al., 2016). Chronic kidney patients report experiencing symptoms which 
match with the symptoms of major depression such as, anhedonia and 
feelings of sadness, helplessness, guilt, hopelessness, which are usually 
accompanied by changes in sleep, appetite, and libido (Finkelstein, 2016). 
Furthermore, chronic kidney patients report experiencing high anxiety levels 
during hemodialysis treatment, because it enables and triggers their thinking 
about the long-term health condition, survival and early mortality, financial 
issues, job status and fear of losing a job and getting the treatment (Acar, 
2007). Anxiety, as an emotional reaction which is primarily characterized 
by feelings of tension and physical changes, affects the cognitive process 
(Cates et al., 1996). Physical symptoms of anxiety among CKD patients are 
shown in chest pain, sweating, breathlessness, palpitations with the strong 
cognitive component in a form of the fear of dying. Given the multiplicity 
of issues to worry about and strong apprehension feeling due to the dialysis 
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process; being hooked to hemodialysis machine working as  an artificial 
kidney, with an establishment vascular access on their arms, monitoring 
the dialysate, the fluid cleaning unwanted waste products from patient’s 
blood and,  abundance of medications like analgesic, antimicrobial, 
hypoglycemic, diuretic, antihypertensive, erythropoietin (Sari, 2016) and 
potential medical complications (Sousa, 2008), chronic kidney patients 
face multiple physical strains and psychological challenges. Chronic 
kidney patients are usually very weak following hemodialysis treatment; 
depend on others to take them to and from hospitals or private clinics, 
thus requiring care and support during and after the treatment. This might 
be additional vulnerability chronic patients feel besides the illness itself, 
making them vulnerable and prone to develop depression and anxiety 
(Kocabaşoğlu, 2004). With this study, we aim at investigating the level 
of depression and anxiety among chronic kidney patients and the healthy 
control group. 
Methodology
Sample
This study has been done on a sample of 120 participants, comprising two 
groups, experimental and control. The experimental group consisted of 
60 chronic kidney patients on hemodialysis (27 females and 33 males) at 
Inegöl Hospital in Turkey, and the equivalent of 60 people in control group 
(from different parts of Inegöl city) as representatives of the general healthy 
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population. All participants were over 50 years of age. The convenient 
sampling method was used for participants’ selection with the diagnosis 
of chronic kidney disease diagnosis and no chronic kidney diagnosis as a 
primary selection.  
Procedure
After contacting the administration of Inegöl Public Hospital and acquiring 
permission to contact hemodialysis patients, chronic kidney patients were 
approached. Following ethical consideration, researcher (Baha Kurulmaz) 
found 60 CKD patients, explained study aims and objective (ensuring 
confidentiality) inquired their willingness to participate in the study, after 
what they all agreed. Given their health condition, the researcher chose 
to ask participants all questions, one by one, and circled their responses. 
Participation was voluntary and all went well. After collecting the data from 
experimental group, researcher reached 60 people, older than 50 years of 
age (in order to match experimental group), explained study aim and asked 
them to participate in the study. After they agreed, researcher again (to 
follow the same procedure) asked participants all questions, one by one, 
and circled their responses. Collected data has been entered into SPSS 20, 
which was used to analyze and evaluate data collected. 
Research questions and hypothesis
This study aimed to investigate depression and anxiety levels among 
chronic kidney patients, experimental, and healthy control group.
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Hypotheses
H1: Chronic kidney patients will score higher on depression scale compared 
to the general population
H2: Chronic kidney patients will score higher on anxiety scale compared 
to the general population.
Measurements
To measure depression and anxiety level of participants, two scales were 
used, Beck Depression Inventory and level in study groups we used Beck 
Depression Inventory BDI and State-Trait Anxiety Inventory STAI. BDI 
(created by A. T. Beck), is a 21-item self-report test presented in a multiple-
choice format, which measures presence and degree of depression in 
adolescents and adults consistent with the DSM-5, evaluating 21 symptoms 
of depression, 15 of which cover emotions, four cover behavioral changes, 
and six somatic symptoms. Each answer is scored on a scale value of 0-3. 
Between 1-10 these ups and downs are considered normal, between 11-
16 mild mood disturbances, between 17-20 borderline clinical depression, 
between 21-30 moderate depression, between 31-40 severe depression and 
over 40 extreme depression. 
The State-Trait Anxiety Inventory (STAI, Spilberger, 1989) is a commonly 
used measure of trait and state anxiety. Form TX-2 is the most popular 
version which is also used in this research. It has 20 items for assessing trait 
anxiety. Trait anxiety items include: “I worry too much over something 
that really doesn’t matter” and “I am content; I am a steady person.” All 
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items are rated on a 4-point scale (e.g., from “Almost Never” to “Almost 
Always”). Higher scores indicate greater anxiety. Considering our 
participants’ background we used Turkish versions of both inventories, 
translated, adopted and already used in similar studies in Turkey.  BDI 
has been adapted to Turkish language by Hisli (1989) and STAI has been 
adapted to Turkish language by Öner ve Le Comte (1983). 
Results
Given our research aim, investigating depression and anxiety levels, 
central tendency measures, namely mean scores were, whose differences 
were further tested using t-test. Below are tables with of mean scores 
results and t-test results on depression level among both, experimental 
and control groups. 
Participants
N Mean
Std. 
Deviation
Std. Error 
Mean
Depression total/
Experimental group
Depr total/ Control 
group
60 18,5000 7,31031 ,94376
60 12,6667 5,74210 ,74130
Table 1.  Depression level, mean scores for both groups.
Table one shows depression level mean scores and standard deviation of 
both, experimental and control group. Depression level mean scores of 
experimental group is 18.500 while the mean of control group is 12.667. 
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Levene’s Test for 
Equality of Variances
t-test for Equality of Means
F Sig. t Df Sig. 
(2-tailed)
Mean 
Difference
Std. Error 
Difference
95% Confidence Interval 
of the Difference
Lower Upper
Depres. 
total
1,898 ,171 4,861 118 ,000 5,8333 1,20009 3,45684 8,20983
4,861 111,731 ,000 5,8333 1,20009 3,45545 8,21121
Table 2: T-test scores on depression for equality of means, both groups
Table two shows t-test results for depression for both control and 
experimental group. As we can see, sig.(2-tailed) the value is ,000 indicating 
statistically significant difference in depression scores between two groups. 
Anxiety levels were also measured and results are shown in the table below.
Participants
N Mean Std. Deviation Std. Error Mean
Anxiety total/
Experimental group
Anxiety total/ Control 
group
60 40,7667 10,77091 1,39052
60 32,4000 7,80309 1,00737
Table 3: Anxiety level, mean scores for both groups
This table shows mean scores and standard deviation for anxiety level 
of both experimental and control groups. As we can see, anxiety mean 
scores of the experimental group is 40, 7667 while mean scores results for 
control group is 32.4. Significance was further tested with t -test and table 
40
Epiphany: Journal of Transdisciplinary Studies
below shows results.
Levene’s Test for 
Equality of Variances
t-test for Equality of Means
F Sig. t Df Sig. Mean 
Difference
Std. Error 
Difference
95% Confidence 
Interval of the 
Difference
Lower Upper
Anxiety 
total
8,332 ,005 4,873 118 ,000 8,36667 1,71707 4,96639 11,76694
4,873 107,556 ,000 8,36667 1,71707 4,96297 11,77036
 
Table 4: T-test results for both groups
In the independent t-test testing, two unrelated groups on the same 
continuum were compared. As we can see, 005 which is equal to 005 
which means that the variances are at the limit of homogeneity, but in the 
sig.(2-tailed) the value is ,000, what indicates a statistically significant 
difference between two groups when anxiety levels were compared. 
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DISCUSSION
The aim of this study was to investigate depression and anxiety levels 
among chronic kidney patients. We used quasi-experimental research 
design whereby, from a total of 120 participants, we had 60 chronic kidney 
patients in the experimental group and 60 from general (no kidney failure 
diagnosis) in the control group. To measure depression Beck Depression 
Inventory and The State-Trait Anxiety Inventory were used to measure 
depression and anxiety levels. Since our aim was to investigate depression 
and anxiety levels among people with chronic kidney disease and no chronic 
kidney disease, which were the only selection criteria and no additional 
demographic information was inquired from participants. 
Depression level in among chronic kidney patients and control group 
As hypothesized, we found higher depression levels in the experimental 
group, among chronic kidney patients when compared to control group. 
Results indicate depression mean scores of experimental group 18.5, and 
12. 66 in control group.  Results of t-test indicate p =, 000 which less than 
0.05 indicating statistically significant difference in means results between 
the groups.  We can here say that the average of the experimental group 
from BDI match the criteria of depression according to BDI scoring. Our 
results match similar previous research and studies which also showed 
higher depression rates among CKD.
Chronic illnesses are difficult to cope with. From the beginning to the end, 
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chronic diseases indicate many challenges and problems for a patient with 
chronic illness diagnosis. Life quality of people with chronic kidney failure 
is negatively affected due to serious physical changes, losing strength, 
fear of death, fear of losing a job. CKD patients are mostly treated with 
hemodialysis, scheduled by the hemodialysis services and as expected, 
their lives are shaped by the disease, its treatment, and outcome. Several 
similar studies are in line with this study. For example, Chang et al., (2013) 
conducted a study with 270 CKD patients and found 61 individuals met the 
criteria for depression based on the Taiwanese Depression Questionnaire, 
which translates to a crude prevalence of 22.6%. Also, Stasiak et al., 
(2014) conducted a study Brasil 128 CKD patients and also found 22.6% 
of hemodialysis patients suffering from depression.
Boing et al., (2012) conducted a study on 1720 chronic kidney disease 
patients and found 16.2% prevalence of depression of among women, 
older individuals, widowed or divorced, and poor ones, and even after 
adjustment for confounders, the prevalence of depression was 1.44 times 
higher among those reporting one chronic disease and 2.25 times higher 
among those reporting two or more diseases when compared to those with 
no diseases. Thus, chronic disease(s) are factors in depression alongside 
socio-economic factors, family factors, income and age that possibly 
contribute to the development of depression.
Egede (2007) conducted a study in the United States, comparing one-year 
prevalence of depression in 10,500 patients who have chronic diseases, 
matching them with a healthy control group and results point that patients 
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were three times more likely to be depressed. Depression rate was two 
times more present among patients with hypertension, diabetes, coronary 
artery disease, and heart failure while the rate is three times higher among 
end-stage renal disease, chronic obstructive pulmonary disease and 
cerebrovascular disease patients (Egede, 2007). Studies also indicate more 
depression among children suffering from chronic kidney disease. For 
example, Kogon et al., (2013) conducted a cross-sectional on 44 patients 
aged 9–18 years with chronic kidney disease and found 30% overall 
prevalence of depression, indicating that depression is a common issue even 
for children with chronic kidney disease. Based on the study, we might say 
that not only adults but also children might face depression due to chronic 
kidney disease and its outcomes. 
A possible explanation of high prevalence of depression among chronic 
kidney disease patients lies in the fact that kidney disease is very 
challenging disease requiring serious, ongoing and demanding treatment 
techniques which might be factors contributing to patients depression 
level. Chronic kidney disease is most commonly efficiently treated with 
kidney transplantation however, studies state depression might continue 
even after the transplantation, as demonstrated by Müller and his colleague 
(2015) study. Similarly, Corruble et al., (2010) conducted a study with 390 
chronic kidney disease patients from waiting-list for kidney transplantation 
whose depression levels were measured in three periods of time; when 
they are added to the list, 12 months later, 24 months later and 3 months 
after transplantation, and found that depressive symptoms progressively 
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increased before transplantation and showed a marked decrease after 
transplantation.
Given the chronic nature of illness itself, necessary and requiring treatment 
procedures, patients with chronic kidney disease must face serious life 
changes and constraints. Although the best treatment for chronic kidney 
failure is kidney transplantation the number of transplants is low and many 
patients end up on waiting-list, patients sometimes wait for years to be 
transplanted. This kidney transplant waiting process poses serious mental 
health threats appearing in a form of anxiety, negative thinking, pessimism, 
hopelessness, which could be serving as roots for depression development. 
Thus, it is no surprise that depression is not only common but most common 
mental health condition among chronic kidney disease patients. Besides, 
patients’ individual and social /professional life is negatively affected 
by the disease itself and the schedule for a dialysis process. The average 
schedule of a patient is 3 days per week and spending 4 hours in hospitals 
or dialysis services per each day, what negatively interferes with patients 
daily functioning, preventing patient to have full social and occupational 
activities. At the same time, being at the hospital and hospital environment 
itself might influence patients thinking, reminding them of their illness and 
inability to have a normal fulfilling life and even the fear for their future if 
they do not receive treatment. This might be also the reason that patients 
lose their hope and become hopeless, factors underling depression.
At the same time, chronic kidney disease patients lose strength and face 
having serious physical changes and constrain in their bodies. Patient’s 
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inability to do the things he/she used to do before the illnesses might instill 
negative thinking about themselves and their capabilities or even the fear of 
losing more strength, making them vulnerable and necessitating help from 
others, making them dependent. Being dependent on others, after someone 
was able to function independently, is a significant factor which might 
negatively contribute the state of mind (especially man). Independence and 
physical strength is especially important to men since most cultures and 
traditions expect a man to take care of others rather than to be taken care of.
Besides depression, facing chronic illness diagnosis leads to anxiety 
because diagnosis indicates a new phase of life with a serious, chronic 
condition and disease, which is restraining in nature and with troubled and 
uncertain future. Inability to picture the future and have many questions 
about the disease is natural but might be anxiety provoking.  Uncertainty 
and anxiety might be factors which might turn into depression after a while. 
However, it should also be noted that there are other factors which 
contribute to depression development which we did not include as variables 
in our study, factors such as, presence of other chronic or non chronic 
illnesses, gender, marital status, socio-economic status and income, family 
relationships etc, which could also have played a role in depression level 
among our participants  
Anxiety levels among chronic kidney patients and the control group
As hypothesized, chronic kidney patients scored higher on anxiety in 
comparison to the general population, control group. Anxiety levels mean 
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scores for the experimental group is 40.76 and mean scores of 32. 30 in 
the control group. T-test results indicate p =, 000 which less than 0.05, 
indicating the statistically significant difference between experimental and 
control group. Thus, the second hypothesis is also accepted showing higher 
anxiety levels among chronic kidney patients when compared to control 
group. 
Ottaviani et al., (2016) conducted asimilar study with 100 chronic kidney 
disease patients in Sao Paulo, Brazil, finding 33.0% of chronic renal 
patients diagnosed with anxiety. Theofilou (2011), conducted similar study 
144  patients and found women presented significantly higher scores than 
men in trait anxiety measured by STAI II. 
Müller and colleagues (2015) concluded anxiety to be surprisingly constant 
after and before the transplantation. Corruble et al., (2010) measured anxiety 
levels in three periods of time, when they are added to the list, 12 months 
later, 24 months later and 3 months after transplantation on 390 chronic 
kidney disease patients from waiting-list for kidney transplantation and 
found that anxiety symptoms progressively increased before transplantation 
and showed a marked decrease after transplantation.
In addition, Lee (2013) has conducted a study with 208 pre-dialysis chronic 
kidney patients and found 27.6% anxiety prevalence among these patients. 
Cukor and colleagues (2008) with their study show 45.7% of chronic kidney 
disease patients have met the criteria for anxiety disorder, with specific 
phobias of 26.6% as most prevalent one followed by 21% of panic disorder. 
Besides, chronic kidney disease interferes with other bodily functions. 
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For example, Turkish Kidney Foundation (2012) indicate sexual dysfunction 
among chronic kidney disease patients, what further creates marital 
problems, pointing to 70% of male patients having impotence issues and 
around 50% having marital problems. So, chronic kidney disease is also 
related to sexual problems marital problems, which additionally complicate 
already vulnerable physical and mental health of chronic kidney patients. 
Although we did not investigate these variables, it is possible that they 
could have influenced study results.
Hence, in line with previous studies, the prevalence of anxiety is quite high 
among chronic kidney disease patients. Facing chronic illness diagnosis 
requires different coping skills. Poor or lack of effective coping strategies and 
skills might be anxiety provoking. Adaption to this new stressful situation 
is hard, not only for the patient but also his/her family members as well. 
Disease outcomes like physical changes, itching, sleeping problems, and 
sexual problems cannot be controlled by the patients, which in turn might 
make patients anxious, lonely and hopeless. Feeling lonely and isolated 
pushes patients away from family members and friends, because patients 
might be feeling uncomfortable to talk about the illness and its outcomes in 
order to avoid worrying family members. Chronic illness diagnosis usually 
induces fear and anxiety due to the fear about the future, wondering what 
will happen and become of them.  At the same time, some studies indicate 
about 57 % of depression cases showed evidence of comorbid anxiety, 
while only 28% of those with clinically significant anxiety had concurrent 
depression. So, comorbidity of mental health disorders is common for 
48
Epiphany: Journal of Transdisciplinary Studies
patients with chronic disease (Braam et al., (2014). 
Still, we ought to acknowledge the possibility of other factors contributing 
to anxiety development like genetics, gender, age, life quality, family and 
social support, which we did not include in our study, which might be having 
a role in our study results and should be included in the future study. Family 
support and lack of it plays a significant role in disease recovery and mental 
health problems prevention. Family members play a very important role 
and also should be included to help chronic kidney disease patients because 
the entire family is somehow influenced by the disease.
 Conclusion 
Depression and anxiety are the most common mental health disorders to be 
found among chronic kidney disease patients. Possible reasons for anxiety 
and depression development among chronic kidney disease patients lies 
partially in the disease itself, partially in treatment techniques commonly 
used to treat this condition and partially in disease’s overall aftermath. 
Given the prevalence of depression and anxiety disorders among chronic 
kidney disease patients hospital services should offer psychological support 
and help to patients suffering from chronic kidney disease as well as their 
family members and some sort of holistic service. Besides diminishing and 
treating chronic illness and relieve negative outcomes of disease and its 
treatment, a holistic approach could be very useful in helping patients and 
family members cope on individual and group level. 
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